143 related articles for article (PubMed ID: 9651600)
1. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
Bouakaz A; de Jong N; Cachard C; Jouini K
Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
3. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular opacification after intravenous injection of Albunex. The effect of different administration procedures.
Sonne HS; Christensen PD; Muan B; Assentoft J; Haider T; Kristensen BO
Int J Card Imaging; 1995 Mar; 11(1):47-53. PubMed ID: 7730681
[TBL] [Abstract][Full Text] [Related]
5. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
[TBL] [Abstract][Full Text] [Related]
6. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
Yvorchuk KJ; Sochowski RA; Chan KL
J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
[TBL] [Abstract][Full Text] [Related]
7. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
Leischik R; Beller KD; Erbel R
Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
[TBL] [Abstract][Full Text] [Related]
9. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
[TBL] [Abstract][Full Text] [Related]
10. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
[TBL] [Abstract][Full Text] [Related]
11. Myocardial contrast enhancement after intravenous injection of sonicated albumin microbubbles: a transesophageal echocardiography dipyridamole study.
Voci P; Bilotta F; Merialdo P; Agati L
J Am Soc Echocardiogr; 1994; 7(4):337-46. PubMed ID: 7917341
[TBL] [Abstract][Full Text] [Related]
12. Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements.
de Jong N; Hoff L; Skotland T; Bom N
Ultrasonics; 1992 Mar; 30(2):95-103. PubMed ID: 1557838
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular opacification by intravenous contrast echocardiography.
Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent.
Wilson B; Shung KK; Hete B; Levene H; Barnhart JL
Ultrasound Med Biol; 1993; 19(3):181-91. PubMed ID: 8511824
[TBL] [Abstract][Full Text] [Related]
15. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
Porter TR; Xie F; Kilzer K
J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
[TBL] [Abstract][Full Text] [Related]
16. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of left ventricular volume by contrast echocardiography].
Iwamori K; Ishikawa K
Nihon Rinsho; 1998 Apr; 56(4):926-9. PubMed ID: 9577610
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
[TBL] [Abstract][Full Text] [Related]
19. Quantification of microbubble destruction of three fluorocarbon-filled ultrasonic contrast agents.
Moran CM; Anderson T; Pye SD; Sboros V; McDicken WN
Ultrasound Med Biol; 2000 May; 26(4):629-39. PubMed ID: 10856626
[TBL] [Abstract][Full Text] [Related]
20. Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent.
Fisher NG; Christiansen JP; Leong-Poi H; Jayaweera AR; Lindner JR; Kaul S
J Am Coll Cardiol; 2002 Feb; 39(3):530-7. PubMed ID: 11823094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
